Cargando…

High risk of coronary artery aneurysm in Kawasaki disease

OBJECTIVE: Kawasaki disease (KD) is a vasculitis of unknown aetiology with a high risk of coronary aneurysms if untreated. Timely treatment with intravenous immunoglobulin decreases the risk for coronary artery aneurysms (CAA). In this study, we set out to elucidate the factors associated with the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mossberg, Maria, Mohammad, Aladdin J, Kahn, Fredrik, Segelmark, Mårten, Kahn, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023999/
https://www.ncbi.nlm.nih.gov/pubmed/33150451
http://dx.doi.org/10.1093/rheumatology/keaa512
_version_ 1783675220403421184
author Mossberg, Maria
Mohammad, Aladdin J
Kahn, Fredrik
Segelmark, Mårten
Kahn, Robin
author_facet Mossberg, Maria
Mohammad, Aladdin J
Kahn, Fredrik
Segelmark, Mårten
Kahn, Robin
author_sort Mossberg, Maria
collection PubMed
description OBJECTIVE: Kawasaki disease (KD) is a vasculitis of unknown aetiology with a high risk of coronary aneurysms if untreated. Timely treatment with intravenous immunoglobulin decreases the risk for coronary artery aneurysms (CAA). In this study, we set out to elucidate the factors associated with the risk of developing CAA. METHODS: Records of all KD-diagnosed children in Skåne between 2004 and 2014 were collected and clinical and demographic data were compiled. KD is defined according to the revised American Heart Association diagnostic criteria and classified as either complete KD (cKD) or incomplete KD (iKD). RESULTS: KD was diagnosed in 77 children and CAA was found in 31% (n = 24). Children with CAA were younger compared with children without (median; 20 vs 34 months) and intravenous immunoglobulin treatment within 10 days was less likely to be received (75% vs 91%). In children presenting with iKD, 47% developed CAA compared with 21% in cKD patients. Using multivariate analysis, an association between the risk of CAA with low age in children with iKD was observed. CONCLUSION: The risk of CAA development is disturbingly high in young children with iKD. This highlights the importance of rapid intense treatment and vigilance in infants, who are the most difficult to diagnose, in order to reduce the frequency of CAA.
format Online
Article
Text
id pubmed-8023999
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80239992021-04-13 High risk of coronary artery aneurysm in Kawasaki disease Mossberg, Maria Mohammad, Aladdin J Kahn, Fredrik Segelmark, Mårten Kahn, Robin Rheumatology (Oxford) Clinical Science OBJECTIVE: Kawasaki disease (KD) is a vasculitis of unknown aetiology with a high risk of coronary aneurysms if untreated. Timely treatment with intravenous immunoglobulin decreases the risk for coronary artery aneurysms (CAA). In this study, we set out to elucidate the factors associated with the risk of developing CAA. METHODS: Records of all KD-diagnosed children in Skåne between 2004 and 2014 were collected and clinical and demographic data were compiled. KD is defined according to the revised American Heart Association diagnostic criteria and classified as either complete KD (cKD) or incomplete KD (iKD). RESULTS: KD was diagnosed in 77 children and CAA was found in 31% (n = 24). Children with CAA were younger compared with children without (median; 20 vs 34 months) and intravenous immunoglobulin treatment within 10 days was less likely to be received (75% vs 91%). In children presenting with iKD, 47% developed CAA compared with 21% in cKD patients. Using multivariate analysis, an association between the risk of CAA with low age in children with iKD was observed. CONCLUSION: The risk of CAA development is disturbingly high in young children with iKD. This highlights the importance of rapid intense treatment and vigilance in infants, who are the most difficult to diagnose, in order to reduce the frequency of CAA. Oxford University Press 2020-11-05 /pmc/articles/PMC8023999/ /pubmed/33150451 http://dx.doi.org/10.1093/rheumatology/keaa512 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Clinical Science
Mossberg, Maria
Mohammad, Aladdin J
Kahn, Fredrik
Segelmark, Mårten
Kahn, Robin
High risk of coronary artery aneurysm in Kawasaki disease
title High risk of coronary artery aneurysm in Kawasaki disease
title_full High risk of coronary artery aneurysm in Kawasaki disease
title_fullStr High risk of coronary artery aneurysm in Kawasaki disease
title_full_unstemmed High risk of coronary artery aneurysm in Kawasaki disease
title_short High risk of coronary artery aneurysm in Kawasaki disease
title_sort high risk of coronary artery aneurysm in kawasaki disease
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023999/
https://www.ncbi.nlm.nih.gov/pubmed/33150451
http://dx.doi.org/10.1093/rheumatology/keaa512
work_keys_str_mv AT mossbergmaria highriskofcoronaryarteryaneurysminkawasakidisease
AT mohammadaladdinj highriskofcoronaryarteryaneurysminkawasakidisease
AT kahnfredrik highriskofcoronaryarteryaneurysminkawasakidisease
AT segelmarkmarten highriskofcoronaryarteryaneurysminkawasakidisease
AT kahnrobin highriskofcoronaryarteryaneurysminkawasakidisease